References
- Wu T, Yen T, Lai C. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol. 2011;25(6):681–689.
- Shah S, Jagannathan J, Krajewski K, et al. Uterine sarcomas: then and now. AJR Am J Roentgenol. 2012;199(1):213–223.
- Ricci S, Stone R, Fader A. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecologic Oncology. 2017;145(1):208–216.
- Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428.
- Chen J, Li Y, Wang Z, Committee of the Clinical Trial of HIFU versus Surgical Treatment for Fibroids, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364.
- Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC Press; 2014. p. 141–145.
- Pritts E, Vanness D, Berek J, et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg. 2015;12(3):165–177.
- Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst. 1986;76(3):399–402.
- Chen I, Lisonkova S, Joseph K, et al. Laparoscopic versus abdominal myomectomy: practice patterns and health care use in British Columbia. JOGC. 2014;36(9):817–821.
- Takamizawa S, Minakami H, Usui R, et al. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest. 1999;48(3):193–196.
- Leibsohn S, d'Ablaing G, Mishell DR, et al. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162(4):968–976.
- Bogani G, Cliby W, Aletti G. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol Oncol. 2015;137(1):167–172.
- Bosch TVD, An C, Morina M, et al. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):257–266.
- Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncologica. 2012;51(6):694–705.
- Kildal W, Pradhan M, Abeler VM, et al. Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters. Eur J Cancer. 2009;45(13):2412–2417.
- DeMulder D, Ascher S. Uterine leiomyosarcoma: can MRI differentiate leiomyosarcoma from benign leiomyoma before treatment? AJR Am J Roentgenol. 2018;211(6):1405–1415.